ALCER Share Price

Open 2.00 Change Price %
High 2.00 1 Day 0.00 0.00
Low 2.00 1 Week 0.00 0.00
Close 2.00 1 Month 0.00 0.00
Volume 20 1 Year 0.00 0.00
52 Week High 44.95
52 Week Low 24.00
ALCER Important Levels
Resistance 2 2.00
Resistance 1 2.00
Pivot 2.00
Support 1 2.00
Support 2 2.00
EPA France Most Active Stocks
MT 4.53 12.97%
MT 4.53 12.97%
MT 4.53 12.97%
MT 4.53 12.97%
MT 4.53 12.97%
SOI 1.38 11.29%
SOI 1.38 11.29%
SOI 1.38 11.29%
GSZ 17.56 3.97%
GSZ 17.56 3.97%
More..
EPA France Top Gainers Stocks
ALALO 0.04 33.33%
APAM 33.78 15.72%
APAM 33.78 15.72%
ALSAS 6.29 15.62%
MLLOI 3.80 15.15%
AVQ 0.16 14.29%
DEXB 17.47 13.89%
DEXB 17.47 13.89%
MT 4.53 12.97%
MT 4.53 12.97%
More..
EPA France Top Losers Stocks
MLCAC 8.00 -21.95%
MLDEX 0.30 -18.92%
AVT 0.05 -16.67%
AVT 0.05 -16.67%
AVT 0.05 -16.67%
AVT 0.05 -16.67%
VRNL 0.51 -12.07%
EBPF 85.50 -10.00%
ALMAS 0.79 -9.20%
TONN 1.01 -8.18%
More..

Cerep SA (EPA: ALCER)

ALCER Technical Analysis 5
As on 30th Jul 2014 ALCER Share Price closed @ 2.00 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 2.07 & Strong Sell for SHORT-TERM with Stoploss of 2.05 we also expect STOCK to react on Following IMPORTANT LEVELS.
ALCER Target for December
1st Target up-side N/A
2nd Target up-side N/A
3rd Target up-side N/A
1st Target down-side N/A
2nd Target down-side N/A
3rd Target down-side N/A
ALCER Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Drug Manufacturers - Major
Offical website http://www.cerep.fr
ALCER Address
ALCER
Le bois l'Ev
Celle l'Evescault, 86600
France
Phone: 33 5 49 89 30 00
Fax: 33 5 49 43 21 70
ALCER Latest News
Eurofins raises 296 million euros by equity issuance   Reuters Key Development   - 08th Sep 16
Eurofins scientific acquires VRL Laboratories in U.S.   Reuters Key Development   - 01st Sep 16
Interactive Technical Analysis Chart Cerep SA ( ALCER EPA France )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Cerep SA
ALCER Business Profile
Cerep SA provides in vitro pharmacology, in vitro ADME-Tox, and in vivo PK services to pharmaceutical and biotechnology companies worldwide. The company offers various research services, including compound management, high-throughput screening, in vitro safety profiling, lead optimization profiling, in vitro ADME profiling, and in vivo PK; and custom research services comprising assay development, profile design, and data interpretation, as well as scientist-to-scientist communications. Its platforms cover a range of target classes, such as GPCRs, kinases, nuclear receptors, and employing methods; and assay types, including radioligand binding assays, calcium mobilization and cAMP measurement, transporter/uptake assays, bioluminescent, and other fluorescent-based assays. The company also provides BioPrint profiles and services, a homogenous pharmacology and ADME database comprising data sets, such as chemical descriptors, compound descriptors, and in vivo effects of drugs, which offer a resource for supporting decision making in drug discovery. Cerep SA was founded in 1989 and is headquartered in Celle l'Evescault, France. As of February 27, 2013, Cerep SA operates as a subsidiary of Eurofins Scientific SA.